<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE297nnn/GSE297530/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297530</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Interferon regulatory factor 5 regulates bone remodeling via orchestration of osteoclast lineage-osteoblast coupling</name><description>Bone remodeling is orchestrated by the balanced activity of bone-resorbing osteoclasts and bone-forming osteoblasts. Interferon regulatory factor 5 (IRF5), a member of the IRF family of transcription factors, serves as a critical regulator of macrophage immune-related activity. However, macrophages also serve as the precursor cell of osteoclasts where the role of IRF5 in osteoclast-mediated bone remodeling in vivo remains undefined. Here, we find that IRF5 exhibits nuclear localization specifically in preosteoclasts during macrophage-osteoclast transition in vitro. In turn, myeloid cell-specific Irf5 conditional knockout (Irf5ΔM/ΔM) mice exhibit a significant osteopenic phenotype. Unexpectedly, osteoclast activity remained unaltered, while osteoblastic bone formation was significantly reduced. Interestingly, while conditioned media from wild-type preosteoclasts and osteoclasts increase the osteogenic potential of osteoblastic cells, this stimulatory activity was largely abrogated in conditioned media recovered from Irf5ΔM/ΔM preosteoclasts and osteoclasts. Genome wide analysis further revealed that the Irf5-deficient osteoclast lineage displays major changes in transcriptional programs related to extracellular matrix organization, bone development, and Notch signaling. Taken together, we have identified IRF5 as a novel osteoimmune transcription factor that coordinates bone remodeling by regulating osteoclast lineage-mediated bone coupling, thus providing novel insights into developing effective preventive and/or therapeutic strategies against metabolic bone diseases.</description><dates><publication>2026/07/29</publication></dates><accession>GSE297530</accession><cross_references><GSM>GSM8994097</GSM><GSM>GSM8994096</GSM><GSM>GSM8994098</GSM><GSM>GSM8994093</GSM><GSM>GSM8994095</GSM><GSM>GSM8994094</GSM><GPL>23479</GPL><GSE>297530</GSE><taxon>Mus musculus</taxon><PMID>[42331106]</PMID></cross_references></HashMap>